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Abstract
Objectives The aim of this study was to evaluate impact of 3D printed models on decision-making in context of laparoscopic
liver resections (LLR) performed with intraoperative ultrasound (IOUS) guidance.
Methods Nineteen patients with liver malignances (74% were colorectal cancer metastases) were prospectively qualified for
LLR or radiofrequency ablation in a single center fromApril 2017 to December 2018. Models were 3DP in all cases based on CT
and facilitated optical visualization of tumors’ relationships with portal and hepatic veins. Planned surgical extent and its changes
were tracked after CT analysis and 3D model inspection, as well as intraoperatively using IOUS.
Results Nineteen patients were included in the analysis. Information from either 3DP or IOUS led to changes in the planned
surgical approach in 13/19 (68%) patients. In 5/19 (26%) patients, the 3DP model altered the plan of the surgery preoperatively.
In 4/19 (21%) patients, 3DP independently changed the approach. In one patient, IOUS modified the plan post-3DP. In 8/19
(42%) patients, 3DP model did not change the approach, whereas IOUS did. In total, IOUS altered surgical plans in 9 (47%)
cases. Most of those changes (6/9; 67%) were caused by detection of additional lesions not visible on CT and 3DP.
Conclusions 3DP can be helpful in planning complex and major LLRs and led to changes in surgical approach in 26.3% (5/19
patients) in our series. 3DP may serve as a useful adjunct to IOUS.
Key Points
• 3D printing can help in decision-making before major and complex resections in patients with liver cancer.
• In 5/19 patients, 3D printed model altered surgical plan preoperatively.
•Most surgical plan changes based on intraoperative ultrasonography were caused by detection of additional lesions not visible
on CT and 3D model.
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Abbreviations
3DP 3D printing
ALLPS Associating liver partition and portal vein
ligation for staged hepatectomy
IOUS Intraoperative ultrasound
LLR Laparoscopic liver resection
Introduction
Laparoscopic liver resection (LLR) has been widely adopted
as an acceptable and often preferable approach for resections
in patients with hepatic malignancies, including colorectal
intrahepatic metastases, over the last 20 years. Recent meta-
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analyses and studies, including OSLO-COMET randomized
controlled trial, proved LLRs to be non-inferior and in many
cases superior to open surgery, especially in terms of reduced
blood loss, lower or similar morbidity, and comparable mor-
tality and survival [1–5]. A minimally invasive approach
comes, however, with some limitations. Magnified view,
which is considered a great advantage of laparoscopy, also
disrupts the natural perception of anatomy and restricts the
overview. Additionally, lack of tactile sensation is often de-
scribed as a reason for surgeons’ disorientation during the
procedure [6]. This is especially true in more difficult resec-
tions, including sectionectomies of lesions in postero-superior
locations that require extensive liver mobilization and work
with not fully satisfactory field of view [7]. To overcome these
obstacles, intraoperative ultrasound (IOUS) has been widely
used. IOUS is now strongly recommended by the 2018
Southampton Consensus Guidelines to be available in every
LLR case, as it can potentially help in planning the resection
line and precise tumor location [8]. Having said that, it would
be preferable for IOUS to only confirm or slightly alter pre-
operative findings, with an accurate surgical plan having been
established prior to the procedure. For this reason, advance-
ments in presurgical imaging are explored. They, however,
have often been burdened by high costs of proprietary soft-
ware or poor rendering quality. Moreover, images presented
by specialized software are still assessed on flat 2D screen.
The rise of modern 3D visualization techniques, including 3D
printing (3DP) and augmented reality, tries to present the
models in more realistic ways, allowing the surgeon haptic
feedback and real-time visualization. 3DP has been employed
in recent years to support clinicians from various fields and
was found to be beneficial in terms of perioperative outcomes
[9–11]. There is a major gap in literature regarding how 3DP
models affect decision-making and, most importantly, clinical
outcomes. Although a few recent publications attempted to
quantitatively assess 3DP impact, most research provided con-
clusions based on questionnaires and subjective results [12].
This is also the case with the field of liver resections as no
prospective studies have been published so far, especially in-
volving IOUS use.
The aim of this study was to evaluate impact of 3D printed
models on decision-making in context of LLRs performed
with IOUS guidance.
Materials and methods
This study was approved by the local research Ethical
Committee following the guidelines of the Declaration of
Helsinki of 1975 with its later revisions. All subjects gave
their informed consent for inclusion before they participated
in the study. This research is a part of a trial registered in
ClinicalTrials.gov database under identification number
NCT03744624. The clinical trial is expected to enroll 85
patients by December 2022; thus, this study can be
considered a preliminary study that allows continuing with
the protocol. We followed a cost-effective method of develop-
ing full-sized 3DP liver models introduced by Witowski et al
[13]. Accuracy of this approach has been previously con-
firmed [14]. Fifteen out of 19 patients have been previously
reported in the latter study. This prior article dealt with inves-
tigating precision of models, whereas in this manuscript we
report on clinical impact.
Consecutive patients with liver tumors were qualified to
undergo LLR or radiofrequency ablation (RFA) with the use
of IOUS from April 2017 to December 2018 in a tertiary
referral center and prospectively included to study. Study par-
ticipants’ characteristics are presented in Table 1. Initially,
surgery was planned after CT assessment made by a multidis-
ciplinary team including surgeons and radiologists.
Subsequently, a personalized model was 3D printed and de-
livered to surgical team at least 5 days prior to the procedure.
After reviewing 3DP model and discussing it within the team,
primary decision about surgery extent was reviewed and any
changes were noted. Finally, the ultimate decision taken intra-
operatively with the use of IOUS was recorded. IOUS was
considered a reference standard.
Nineteen participants were included into analysis and,
based on CT evaluation, 16 were qualified for LLR, 2 partic-
ipants for RFA, and in one case a laparoscopic associating
liver partition and portal vein ligation for staged hepatectomy
(ALLPS) procedure was planned. Median operative time was
210 min (range 30–540 min) and median blood loss 450 mL
(range 0–2600). There have been two conversions to open
surgery.
Imaging
All images were acquired according to the clinical protocol on
a 64-slice GE Optima CT660 system (GE Medical Systems).
CT protocol included pre- and post-contract imaging in arte-
rial, hepatic/portal, and delayed phases. Hepatic phase, which
was used for segmentation, was acquired 30 s after arterial





Parameters (N = 19)
Male/female 13/6
Age, median (range), y 64.5 (35–81)
BMI, mean ± SD 26.2 ± 3.7
Child-Pugh A/B 17/2
mCRC/HCC/SFT 14/4/1
mCRC colorectal liver metastases, HCC
hepatocellular carcinoma, SFT solitary fi-
brous tumor
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axial images were slice thickness of 1.25 mm, 120 kVp, total
collimation width 40 mm, table feed per rotation 39.375 mm,
and 512 × 512 matrix.
3D printing
Detailed technical note of model development was described
previously [13]. Compared to the original methodology, we
have been using 3D Slicer software (open source; slicer.org)
for segmentation instead of Horos (open source; horosproject.
org) [15]. Segmentation was performed by J.W. and reviewed
by A.G. (radiologist with 15-year experience in
abdominopelvic imaging). Segmentation used semi-
automatic algorithms including region growing and
thresholding to create initial regions of interests. They were
then corrected with manual tools such as paint brush/eraser or
prebuilt level tracing for pixel-level accuracy. It is important to
mention that this part of methodology is crucial to ensure
printed model accuracy.
Segmented parts of hepatic and portal veins, liver paren-
chyma, and tumors were 3D printed using Ultimaker 2+ print-
er (Ultimaker) with polylactic acid filaments. Developed parts
were assembled to create a mold, which was smoothed and
coated with resin and subsequently casted with transparent
silicone. In comparison to primary development technique,
we also reduced silicone curing time from 72 to 48 h and
replaced bonding printed parts using cyanoacrylate adhesive
with plastic friction welding due to problems with silicone
leaking. In most cases, process of preparing 3DP models re-
quires at least five working days (Fig. 1).
Endpoints
Primary endpoints of this study were changes in the extent of
surgical resection, moments when decisions have been made
and their significance. Changes were considered major if they
involved more than one liver segment in accordance to
Couinaud’s classification (considering segments 4a and 4b
as two separate segments). Data were stratified by 3DP
models changing surgical approach without any further
change from IOUS, 3DP models changing approach altered
later by IOUS, and circumstances where 3DP did not identify
a change in approach whether IOUS did.
Results
3D printed models were developed, delivered, and used by
surgical team as planned in study design (Fig. 2). In 5/19
(26.3%) patients, surgical plan was changed after examination
of 3D liver models and four of these changes (21% of all
patients) were considered major (Table 2). In 4/19 (21%) pa-
tients, 3DP model changed the surgical plan which was not
further altered by IOUS. In one (5.3%) patient, after 3DP
changed the approach, it was modified again after IOUS. In
8/19 (42.1%) patients, 3DP model did not change the ap-
proach, whereas IOUS did.
In total, after IOUS guidance, decision about surgical ex-
tent was altered in 9/19 (47.4%) patients, including two situ-
ations where patients were disqualified from the surgery.
Majority of these changes—6 out of 9 (66.7%)—involved a
maximum of one anatomical segment. Six surgical plan
changes based on IOUS included resection or RFA of addi-
tional lesions that were not visible on preoperative imaging
(patients 5, 6, 7, 10, 11, 13).
Discussion
In our study, we have shown that 3DP models used preoper-
atively can change the surgical plan, in some cases altering the
surgery extent significantly. It seems that 3DP models are
especially useful as a tool for general visual assessment of
tumor location and “visual volumetry.” This approach to
roughly estimating residual liver volume and predicting pre-
served liver function can be found appropriate in patients un-
dergoing major or complex LLRs.
Fig. 1 Examples of 3D printed models used for preoperative planning.
Life-sized models were developed with by standard 3D printing and
silicone casting. Structures were marked as follows: green, lesions;
magenta, portal veins; blue, hepatic veins with inferior vena cava
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Out of around 20 research papers that have been published
in the field of 3DP in liver surgery, none assess quantitatively
how models affect decision-making and most of them lack
description about clinical use [16, 17]. Igami et al displayed
feasibility of using 3DPmodels in choosing liver partition line
[18] and earlier in determining resection line before small
hepatectomy of tumor invisible in IOUS [19]. Selecting and
evaluating optimal resection line was also performed by
Oshiro et al who confirmed benefits of this approach [20].
These publications, however, did not lead to measurable
change in the operative approach. Our study builds up on that
initial evidence, suggesting that 3DP can help not only in
choice of resection line but in determining surgical extent.
Also, we demonstrated clinical feasibility as all of the models
were used prospectively in patient care.
Role and diagnostic accuracy of both CT and IOUS in
LLRs have been widely explored in literature. IOUS greatest
value lies in providing surgeons with real-time control during
resection and higher than preoperative CT diagnostic accuracy
in regards to detecting lesions, with its sensitivity estimating
around 90% [21–23]. Ferrero et al found that the use of IOUS
changed surgical strategy in 27.2% of all cases, out of which
83.6% changes were due to new lesions detected by IOUS
[22]. New tumors explored with IOUS are usually smaller
than 10 mm [22, 24, 25]. Detection of new lesions was also
noticeable in our study, as it was a reason for most
intraoperative decision changes. 3DP models will not detect
new lesions and their diagnostic sensitivity can be as high as
primary imaging. Still, our study showed that in 26.3% of
patients, surgical plan was changed, even without new malig-
nancies. This can be because of better insight into spatial re-
lationships between lesions and liver vasculature. These rela-
tionships can possibly be understood based on CT analysis
only, but it strictly depends on surgeon’s knowledge of radio-
logical anatomy. 3DP models, however, do not require con-
siderable experience to quickly, easily, and fully comprehend
vascular structure in each case, which makes them potentially
more approachable in operative planning. Additionally, it is
worth mentioning that IOUS never reverted the decision about
surgery extent to the initial one after CT analysis.
Reports also suggest IOUS being beneficial in terms of
identifying boundaries of resection intraoperatively [26–28].
Frankly, to our best knowledge, these differences have not
been quantitatively researched so far and our series is a start
to this evaluation.
In our opinion, the feasibility of 3D liver models lays in
the proper planning of the extent of liver resection. It is
crucial in patients undergoing major liver resections in or-
der to detect candidates who may suffer from post-
hepatectomy liver failure. Isolating that cohort can allow
clinicians to implement additional safety measures prior to
the procedure and immediately after. Four out of five
Fig. 2 Development of 3D printed liver models. a Raw CT axial image; b CT image with segmentation masks overlay (green, tumor; yellow,
parenchyma; pink, portal vein; blue, inferior vena cava); c Surface rendering of segmented meshes; d 3D printed liver model
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decision changes based on 3DP in our study involved more
than one segment, suggesting this approach could poten-
tially assist in detecting patients at risk.
Aforementioned changes were usually a result of change in
cognitive localization of tumors in the liver. Although our
study did not prove this fundamentally, recently published
research by Wake et al shows that understanding renal tumor
location based solely on CT is poor and significantly im-
proved with 3DP models [29]. Igami et al 2014 research also
suggested that with 3DP liver models surgeons were able to
better comprehend spatial relationships, although with no
quantitative results [19]. Our experience supports those results
and we believe they could be reproduced with liver tumors. In
this study, we focus on the use of computed tomography.
However, methodology is fully applicable to MRI datasets.
The feasibility of 3DP liver models based on MRI was previ-
ously reported by Ripley et al [30].
There are several limitations of our study. First of all, our
study does not have a control group without the use of 3DP
models, which makes it difficult to perform inferential statis-
tics comparing how IOUS itself would change the extent of
resection in patients without newly found lesions. Rather, the
data presented in this series reflects an institutional practice
change in using 3DP anatomic model prospectively in pa-
tient’s care. Also, there are a limited number of patients in-
cluded in the study who underwent LLR for primarily (n = 15/
19; 79%) colorectal intrahepatic metastasis, making it difficult
to generalize the results to patients with other intrahepatic
malignancies. Our study did not look at treatment short- and
long-term outcomes. This should be a subject for larger,
Table 2 Extent of liver resections planned by surgical team after
analysis of patient imaging and 3D printed model, compared to final
decision. Patients in table are stratified into four groups, depending on
reasons for the change of the surgical plan. Final surgical plan was
decided intraoperatively with the assistance of laparoscopic ultrasound
# Surgical plan based on CT Surgical plan based on 3D printed model Final surgical plan (after intraoperative ultrasound)
Changes made after 3DP
1 Left hepatectomy Extended left hepatectomy* Extended left hepatectomy (conversion)
2 Left hepatectomy Segment 1 anatomic resection* Segment 1 anatomic resection
3 Right hepatectomy Extended right hepatectomy* Extended right hepatectomy
4 Extended right hepatectomy Central hepatectomy* Central hepatectomy
Changes made after 3DP and after IOUS
5 Segment 6 anatomic resection Non-anatomic resection (segment
6 with a fragment of segment 7)*
Non-anatomic resection (segment 6 with
fragments of segments 5 and 7)*
Changes made after IOUS
6 RFA of a single lesion RFA of a single lesion Non-anatomic resection*
7 RFA of two lesions RFA of two lesions RFA of three lesions*
8 ALLPS ALLPS Disqualified from ALLPS (dissemination)*
9 Non-anatomic resection Non-anatomic resection Disqualified from resection (dissemination)*
10 Segment 8 anatomic resection Segment 8 anatomic resection Segment 8 anatomic resection with removal
of two minor superficial lesions on
segments 5, 6*
11 Segments 6, 7 bisegmentectomy Segments 6, 7 bisegmentectomy Right hepatectomy*
12 Segments 2, 3 bisegmentectomy with
non-anatomic segment 5 resection
Segments 2,3 bisegmentectomy with
non-anatomic segment 5 resection
Two non-anatomic resections*
13 Right hepatectomy Right hepatectomy Right hepatectomy with segment
3 metastasectomy*
No changes were made
14 Local resection with gallbladder Local resection with gallbladder Local resection with gallbladder
15 Non-anatomic resection Non-anatomic resection Non-anatomic resection
16 Non-anatomic resection Non-anatomic resection Non-anatomic resection
17 Two metastasectomies Two metastasectomies Two metastasectomies
18 Right hepatectomy Right hepatectomy Right hepatectomy
19 Right hepatectomy with segment
2 metastasectomy
Right hepatectomy with segment
2 metastasectomy
Right hepatectomy with segment 2
metastasectomy (conversion)
Asterisks (*) and text in italics denote change of surgical approach
IOUS intraoperative ultrasound, mCRC metastatic colorectal cancer, HCC hepatocellular carcinoma, ALLPS associating liver partition and portal vein
ligation for staged hepatectomy, RFA radiofrequency ablation
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preferably multi-institutional trials that enroll a sufficient
number of patients to show statistically significant results. It
is also important to take action towards quality assurance and
methodology standardization as results of 3DP are strongly
dependent on segmentation. Future studies should also look
at educational aspects of liver models, both for students and
surgeons as well as for patients, as this has been suggested to
be a beneficial area [31–33]. They could also potentially serve
as quality control devices for tumor resections, discussing
approach or feasibility of the surgery, among other
possibilities.
3DP in liver surgery has more challenges ahead: it is still a
relatively expensive method, although use of low-cost ap-
proaches, as suggested by Witowski et al or Watson, could
help with access to this technology [13, 34]. Alternatively,
other 3D visualization techniques including realistic 3D sur-
face rendering or augmented/virtual reality should be explored
and directly compared to 3DP models in future studies [31].
3DP needs to be adopted to new surgical techniques, such as
ALLPS (associating liver partition with portal vein ligation for
staged hepatectomy), and synergized with new imaging
methods in surgery, including intraoperative fluorescence,
contrast-enhanced intraoperative ultrasound, or co-
registration between intraoperative ultrasound and MRI/CT
[35–38].
3DP liver models are feasible in planning LLRs and can
help in establishing surgical plan in major and complex resec-
tions, occasionally changing surgical approach by more than
one segment. This may be especially promising in situations
where IOUS is not available. However, 3DP models will not
increase sensitivity of lesion detection, which confirms the
necessity of IOUS routine use.
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